Dr Matthew Caley
Lecturer in Cell Biology
Research
Skin, Lipids, rare diseases, screening, Extracellular Matrix, Laminin 332
Interests
My research focusses on the skin basement membrane and specifically laminin 332 a three-chained glycoprotein which is copiously secreted by epithelial cells. We have demonstrated an important role for laminin 332 in skin ageing, squamous cell carcinoma invasion, cholesterol transport and in skin immune regulation. To study these diverse functions we have generated co-culture and 3D skin models including models of aged skin that have allowed us to test gene knockdowns and drug treatments. We have also developed and validated a high throughput screen to identify compounds altering cholesterol transport within the skin.Publications
Publications of specific relevance to Predictive in vitro Models2021
(2021). Loss of the laminin subunit alpha-3 induces cell invasion and macrophage infiltration in cutaneous squamous cell carcinoma. Br J Dermatol vol. 184, (5) 923-934. 10.1111/bjd.19471 (2021). Distinctive clinical and histological characteristics of atrophic and hypertrophic facial photoageing. Journal of The European Academy of Dermatology and Venereology vol. 35, (3) 762-768. 10.1111/jdv.170632020
(2020). 3D model of harlequin ichthyosis reveals inflammatory therapeutic targets. American Society For Clinical Investigation Journal of Clinical Investigation 10.1172/JCI1329872019
Hassan S, Purdie KJ, Wang J, Harwood CA, Proby CM, Pourreyron C, Mladkova N, Nagano A, Dhayade S, Athineos D, Caley M, Mannella V, Blyth K, Inman GJ and Leigh IM (2019). A unique panel of patient-derived cutaneous squamous cell carcinoma cell lines provides a preclinical pathway for therapeutic testing. International Journal of Molecular Sciences vol. 20, (14) 10.3390/ijms201434282018
Caley M, Wall IB, Peake M, Kipling D, Giles P, Thomas DW and Stephens P (2018). Development and characterisation of a human chronic skin wound cell line—towards an alternative for animal experimentation. International Journal of Molecular Sciences vol. 19, (4) 10.3390/ijms190410012016
Caley MP, King H, Shah N, Wang K, Rodriguez-Teja M, Gronau JH, Waxman J and Sturge J (2016). Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces. Clinical and Experimental Metastasis vol. 33, (2) 151-165. 10.1007/s10585-015-9765-7Branco MR, King M, Perez-Garcia V, Bogutz AB, Caley M, Fineberg E, Lefebvre L, Cook SJ, Dean W, Hemberger M and Reik W (2016). Maternal DNA Methylation Regulates Early Trophoblast Development. Developmental Cell vol. 36, (2) 152-163. 10.1016/j.devcel.2015.12.0272015
(2015). A novel fully humanized 3D skin equivalent to model early melanoma invasion. Molecular Cancer Therapeutics vol. 14, (11) 2665-2673. 10.1158/1535-7163.MCT-15-0394 (2015). Cytoskeletal protein Flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression. Impact Journals Oncotarget vol. 6, (34) 36426-36440. 10.18632/oncotarget.5536 (2015). Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC. J Natl Cancer Inst vol. 108, (1) 10.1093/jnci/djv293 (2015). Metalloproteinases and Wound Healing. Adv Wound Care (New Rochelle) vol. 4, (4) 225-234. 10.1089/wound.2014.0581Rodriguez-Teja M, Gronau JH, Breit C, Zhang YZ, Minamidate A, Caley MP, McCarthy A, Cox TR, Erler JT, Gaughan L, Darby S, Robson C, Mauri F, Waxman J and Sturge J (2015). AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival. Journal of Pathology vol. 235, (4) 581-592. 10.1002/path.44852014
(2014). The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma. Oncogene vol. 33, (32) 4185-4192. 10.1038/onc.2013.388Peake MA, Caley M, Giles PJ, Wall I, Enoch S, Davies LC, Kipling D, Thomas DW and Stephens P (2014). Identification of a transcriptional signature for the wound healing continuum. Wound Repair Regen vol. 22, (3) 399-405. 10.1111/wrr.121702013
Pellegrino L, Stebbing J, Braga VM, Frampton AE, Jacob J, Buluwela L, Jiao LR, Periyasamy M, Madsen CD, Caley MP, Ottaviani S, Roca-Alonso L, El-Bahrawy M, Coombes RC, Krell J and Castellano L (2013). miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res vol. 41, (10) 5400-5412. 10.1093/nar/gkt245 (2013). Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res vol. 351, (2) 255-268. 10.1007/s00441-012-1410-zPalmieri C, Caley MP, Purshouse K, Fonseca A-V, Rodriguez-Teja M, Kogianni G, Woodley L, Odendaal J, Elliott K, Waxman J and Sturge J (2013). Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer. Br J Cancer vol. 108, (1) 163-169. 10.1038/bjc.2012.540Stephens P, Caley M and Peake M (2013). Alternatives for animal wound model systems. Methods Mol Biol vol. 1037, 177-201. 10.1007/978-1-62703-505-7_10Stephens P, Caley M and Peake M (2013). Alternatives for animal wound model systems. Methods in Molecular Biology vol. 1037, 177-201. 10.1007/978-1-62703-505-7_102012
Ramasamy K, Khatun H, Macpherson L, Caley MP, Sturge J, Mufti GJ, Schey SA and Calle Y (2012). Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells. Br J Haematol vol. 157, (5) 564-579. 10.1111/j.1365-2141.2012.09103.xCaley MP, Kogianni G, Adamarek A, Gronau JH, Rodriguez-Teja M, Fonseca A-V, Mauri F, Sandison A, Rhim JS, Pchejetski D, Palmieri C, Cobb JP, Waxman J and Sturge J (2012). TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis. J Pathol vol. 226, (5) 775-783. 10.1002/path.39582011
Sturge J, Caley MP and Waxmanin J (2011). Authors' reply: Expanding horizons in metastatic prostate cancer treatment. Nature Reviews Clinical Oncology vol. 8, (10) 10.1038/nrclinonc.2011.67-c2Sturge J, Caley MP and Waxman J (2011). Bone metastasis in prostate cancer: emerging therapeutic strategies (vol 8, pg 357, 2011). Nature Reviews Clinical Oncology vol. 8, (10) 568-568. 10.1038/nrclinonc.2011.127Sturge J, Caley MP and Waxman J (2011). Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol vol. 8, (6) 357-368. 10.1038/nrclinonc.2011.672008
Mantripragada KK, Caley M, Stephens P, Jones CJ, Kluwe L, Guha A, Mautner V and Upadhyaya M (2008). Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals. Genes Chromosomes Cancer vol. 47, (3) 238-246. 10.1002/gcc.20525Mantripragada KK, Caley M, Stephens P, Jones CJ, Kluwe L, Guha A, Mautner V and Upadhyaya M (2008). Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type I individuals. Genes Chromosomes & Cancer vol. 47, (3) 238-246. 10.1002/gcc.205252007
Caley M, Wall I, Kipling D, Thomas DW and Stephens P (2007). Development and characterisation of a human cell-based chronic wound bioassay. Wound Repair and Regeneration vol. 15, (6) A133-A133.